Document 2704 DOCN M94A2704 TI Western-blot--does it really help as a confirmatory test in a developing country? DT 9412 AU Buchalter M; Schneider EZ; Nottar VL; Barcellos NT; Ramos MC; Ferreira JT; Balsan AM; Willers DM; Goncalves JE; Mondini LG; et al; IPB--SSDT/AIDS--Rio Grande do sul State Health Secretariat, Porto; Alegre, Brazil. SO Int Conf AIDS. 1994 Aug 7-12;10(1):243 (abstract no. PB0402). Unique Identifier : AIDSLINE ICA10/94369871 AB OBJECTIVE: To evaluate the resolution of the Western-blot as a confirmatory test in addition to the indirect immunofluorescence, through a retrospective study of the laboratory records. METHODS: As a routine, HIV-1 recombinant ELISA is used as a screening test. When positive, the sample is tested with a competitive ELISA and Indirect Immunofluorescence--IFI (Fundacao Osvaldo Cruz-Ministerio de Saude). In case of negative or inconclusive IFI results, a Western-blot is performed. If the Western-blot is negative or inconclusive a new sample is collected after three months for retesting. Since 1990, approximately 20,000 HIV tests were performed at the Central State Public Health Laboratory (Instituto de Pesquisas Biologicas). The samples come from alternative anonymous test sites, STD clinics, blood banks, hospitals or penitentiaries. RESULTS: 98% of the samples with a first ELISA positive are confirmed through the subsequent tests, the remaining 2% present IFI negative or indeterminate results. In a total of 73 samples with at least one positive ELISA and a negative or inconclusive IFI were tested with a Western-blot (Dupont, Sorin or Pasteur), using the CDCs criteria for positivity. Out of these samples, only 23 (31.5%) were positive. Out of the remaining 50 (68.5% of the total), 34 (68.0%) were inconclusive and 16 (32.0%) were negative. CONCLUSION: Considering the high cost of the Western-blot and the low index of resolution for the IFI negatives or indeterminate cases--about 70% of them having to collect new sample--we question the validity of including the Western-blot in the diagnostic flowcharts for public health purposes. DE *AIDS Serodiagnosis *Blotting, Western Brazil Comparative Study *Developing Countries Fluorescent Antibody Technique Human HIV Antibodies/BLOOD HIV Seropositivity/*DIAGNOSIS/IMMUNOLOGY HIV-1/*IMMUNOLOGY Predictive Value of Tests Retrospective Studies MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).